Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label phase 2 study of intravenous ibandronic acid loading dose for painful bone metastases in breast cancer
2006-003441-16Phase 2Completed
- Sponsor
- Roche
- Start
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of ibandronic acid in breast cancer and bone metastases, sponsored by Roche. Started Oct 2006; status: completed.
02
Drugs
ibandronic acid
03
Conditions
breast cancerbone metastases
Beyond the preview
Go deeper on 2006-003441-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003441-16.